<DOC>
	<DOC>NCT02567539</DOC>
	<brief_summary>The study is aimed to evaluate efficacy and safety of re-irradiation for patients with recurrent high grade gliomas after other treatment.</brief_summary>
	<brief_title>Hypofractionated Stereotactic Radiotherapy for Patients With Recurrent High Grade Glioma</brief_title>
	<detailed_description>Investigators designed this study of a re-irradiation with single radiosurgery or hypofractionated intensity modulated radiation therapy (IMRT) with or without temozolomide. Objective of the study is evaluating efficacy and safety of re-irradiation for patients with recurrent high grade gliomas after other treatment.</detailed_description>
	<mesh_term>Glioma</mesh_term>
	<criteria>Age &gt; 18 years Karnosky performance status (KPS) ≥70 Patients aged &gt;70 years with KPS ≥80 Histopathologically confirmed grade IIIIV glioma Estimated survival ≥ 3 months Any Tumor volume Unifocal tumor Interval time from previous radiotherapy ≥ 6mesi Normal liver, Kidney and bone marrow function Written informed consent KPS &lt; 70 Multifocal tumor Other primary cancer Pregnant women</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2015</verification_date>
</DOC>